264
Views
7
CrossRef citations to date
0
Altmetric
Articles

Identification of potential CRAC channel inhibitors: Pharmacophore mapping, 3D-QSAR modelling, and molecular docking approach

&
Pages 81-108 | Received 27 Sep 2018, Published online: 18 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S.L. Wu, L.F. Wang, H.B. Sun, W. Wang & Y.X. Yu. (2020) Probing molecular mechanism of inhibitor bindings to bromodomain-containing protein 4 based on molecular dynamics simulations and principal component analysis. SAR and QSAR in Environmental Research 31:7, pages 547-570.
Read now

Articles from other publishers (6)

Tahmeena Khan & Saman Raza. (2023) Exploration of Computational Aids for Effective Drug Designing and Management of Viral Diseases: A Comprehensive Review. Current Topics in Medicinal Chemistry 23:17, pages 1640-1663.
Crossref
Ruchi Chawla, Varsha Rani, Mohini Mishra & Krishan Kumar. 2022. Computer Aided Pharmaceutics and Drug Delivery. Computer Aided Pharmaceutics and Drug Delivery 217 254 .
Linda Waldherr, Adela Tiffner, Deepti Mishra, Matthias Sallinger, Romana Schober, Irene Frischauf, Tony Schmidt, Verena Handl, Peter Sagmeister, Manuel Köckinger, Isabella Derler, Muammer Üçal, Daniel Bonhenry, Silke Patz & Rainer Schindl. (2020) Blockage of Store-Operated Ca2+ Influx by Synta66 is Mediated by Direct Inhibition of the Ca2+ Selective Orai1 Pore. Cancers 12:10, pages 2876.
Crossref
Bhumi Shah, Palmi Modi & Sneha R. Sagar. (2020) In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences 252, pages 117652.
Crossref
Xiaoqian Lin, Xiu Li & Xubo Lin. (2020) A Review on Applications of Computational Methods in Drug Screening and Design. Molecules 25:6, pages 1375.
Crossref
Sampath Bhuvaneshwari & Kavitha Sankaranarayanan. (2019) Structural and Mechanistic Insights of CRAC Channel as a Drug Target in Autoimmune Disorder. Current Drug Targets 21:1, pages 55-75.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.